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Edited by Stuart FergusonAbstract We have previously shown that homocysteine (Hcy)
can induce monocyte chemoattractant protein-1 (MCP-1) secre-
tion via reactive oxygen species (ROS) in human monocytes.
Here, we show that Hcy upregulates expression of an important
antioxidative protein, thioredoxin (Trx), via NADPH oxidase in
human monocytes in vitro. The increase of Trx expression and
activity inhibited Hcy-induced ROS production and MCP-1
secretion. Of note, 2-week hyperhomocysteinemia (HHcy)
ApoE/ mice showed accelerated lesion formation and parallel
lower Trx expression in macrophages than ApoE/ mice, sug-
gesting that HHcy-induced sustained oxidative stress in vivo
might account for impaired Trx and hence increased ROS pro-
duction and MCP-1 secretion from macrophages, and subse-
quently accelerated atherogenesis.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Atherosclerosis is the leading cause of cardiovascular mor-
bidity and mortality in the world. Hyperhomocysteinemia
(HHcy) has been recognized as an independent risk factor
for this disease for more than 30 years [1]. Despite studies
reporting that diet-induced mild to moderate HHcy accelerates
atherosclerotic lesion development in ApoE/ mice [2], the
mechanisms are still not completely understood.
Recent studies have elucidated that the development of ath-
erosclerosis involves reactive oxygen species (ROS)-induced
oxidative stress and inﬂammation [3]. During the early stage
of atherogenesis, monocytes and T cells are recruited to the
subendothelium. The cell recruitment is mainly regulated by
adhesion molecules and chemokines. One of the most impor-Abbreviations: Trx, thioredoxin; MCP-1, monocyte chemoattractant
protein-1; ROS, reactive oxygen species; Hcy, homocysteine; HHcy,
hyperhomocysteinemia
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doi:10.1016/j.febslet.2008.10.030tant chemokines is monocyte chemoattractant protein-1
(MCP-1). Gu et al. [4] reported that the ablation of
MCP-1 greatly decreased the lesion size in atherosclerotic
LDLR/ mice. We have previously demonstrated that homo-
cysteine (Hcy) enhances vascular inﬂammation by promoting
the expression and secretion of MCP-1 and IL-8 in human
monocytes in vitro, and ROS may mediate the Hcy-induced
MCP-1 expression [5].
Human thioredoxin (Trx) is a ubiquitously expressed multi-
functional protein crucial for the regulation of transcription
factors, modulation of immune response, and especially for
antioxidative defense [6]. Trx reduces the oxidized form of
Trx peroxidase, which then scavenges ROS, such as H2O2
[7], and acts as a redox regulator of signaling molecules and
transcription factors. Trx could maintain a reduced intracellu-
lar microenvironment by reducing protein disulﬁdes under oxi-
dative stress, thereby mediating the cellular response to redox
state [8].
We aimed to determine the role of Trx in Hcy-induced
MCP-1 secretion from monocytes both in vitro and in vivo.
Our data show that Hcy elevated Trx protein in a NADPH
oxidase-dependent manner in human monocytes. Overexpres-
sion of Trx inhibited Hcy-induced ROS production as well
as MCP-1 secretion which might delay atherogenesis. Interest-
ingly, Trx expression was signiﬁcantly decreased after long-
term HHcy stimulation in early stage of ApoE/ mice, which
might hence accelerate atherogenesis.
2. Materials and methods
2.1. Cell culture
Primary human monocytes were isolated from blood of healthy do-
nors as described previously [9]. Murine peritoneal macrophages were
isolated by ﬂushing the peritoneal cavity with ice-cold PBS containing
10% FBS and 1 mM EDTA. Human monocytes (THP-1) and type II
alveolar epithelial cells (A549) were obtained from ATCC. For exper-
iments, THP-1 cells were diﬀerentiated for 24 h with 10 nM PMA.
THP-1 cells were grown in RMPI-1640 containing 10% FBS. A549
cells were cultured in DMEM (Hyclone, Logan, UT) supplemented
with 10% FBS.
2.2. Preparation of cell extracts and Western blotting
Cells extracts were prepared and separated by 12% SDS–PAGE, and
then transferred onto a nitrocellulose membrane as described previ-
ously [9]. Membranes were immunoblotted with anti-Trx antibody
(1:2000) (Santa Cruz Biotechnology, Santa Cruz, CA) and then were
incubated with IRDye-conjugated secondary antibody for 1 h. The
immunoﬂuorescence band was detected by use of the Odyssey infrared
imaging system (LI-COR Biosciences, Lincoln, NE).blished by Elsevier B.V. All rights reserved.
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A549 cells were transfected with 1.5 lg pcDNA3.1-Trx expression
plasmid or pcDNA3.1 plasmid for 24 h by use of cationic polymer
transfection reagent (JetPEI, France) prior to measure ROS generation
or for western blotting.2.4. Measurement of ROS generation
The generation of ROS in A549 cells was detected by horseradish
peroxidase-catalysed chemiluminescence in a light-tight box with a
BPCL Ultra-weak luminescence analyzer (Beijing, China) at 37 C as
described in Ref. [10]. Transfection of A549 cells was performed as
previously described, with 10 lg/ml horseradish peroxidase, 0.5 mM
luminol, and 100 lM Hcy in a total volume of 1 ml.Fig. 1. Eﬀect of Hcy on Trx and Cu, Zn-SOD protein levels in monocytes
incubated with Hcy for various times, (A) and various concentrations or H2O
in the absence or presence of Hcy (100 lM) for 12 h, (C); and Cu, Zn-SOD p
various times (D). *P < 0.05 vs. control (Con), n = 3.2.5. Measurement of MCP-1 protein secretion
Cultured human monocytes were treated with Hcy and some were
pretreated with 1 lM sodium selenite for 24 h, then the supernatant
was harvested 3 days later. MCP-1 concentration was determined on
ELISA (R&D Systems, Minneapolis, MN) [9].2.6. Animals and tissue sample preparations
Female ApoE/ mice, 6 weeks old, were fed normal mouse chow
and water with or without 1.8 g/L DL-Hcy added (n = 8 mice) for 2
weeks. Mice were anesthetized, then blood was drawn and serum har-
vested for determination of plasma Hcy and lipids. Subsequently, per-
itoneal macrophages were isolated for quantitative real-time PCR
analysis. After being removed, the heart was cut transversely. Cryostat. Western blot of Trx protein expression in diﬀerentiated THP-1 cells
2 as positive control, (B); primary cultured human monocytes incubated
rotein expression in diﬀerentiated THP-1 cells incubated with Hcy for
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All treatment of laboratory animals and experimental procedures were
approved by the Institutional Authority for Laboratory Animals Care
of Peking University Health Science Center.
2.7. RNA extraction and quantitative real-time PCR analysis
Total RNA from murine peritoneal macrophages was isolated by
use of Trizol reagent (Promega, Madison, WI). Total RNA was reverse
transcribed with use of a reverse transcription system (Promega, Mad-
ison, WI). All ampliﬁcation reactions involved use of the Mx3000 Mul-
tiplex Quantitative PCR System (Stratagene, La Jolla, CA) on the
basis of SYBR Green I ﬂuorescence. The primer pairs used were as fol-
lows: for mouse Trx1, upstream: 5 0-TCT GCT ACG TGG TGT GGA
CCT-3 0 and downstream: 5 0-TCC TTG TTA GCA CCG GAG AAC-
3 0; for mouse b-actin, upstream: 5 0-ATC TGG CAC CAC ACC TTC-
3 0 and downstream: 5 0-AGC CAG GTC CAG ACG CA-3 0.
2.8. Plasma Hcy and lipids
Plasma total Hcy level was quantiﬁed by gas chromatography–mass
spectrometry. Plasma total cholesterol (TC) and total triglyceride (TG)
levels were assayed with use of kits from Zhong Sheng Bio-technology
(Beijing, China).
2.9. Statistical analysis
Data are presented as means ± SEM and analyzed by one-way AN-
OVA and then the Student–Newman–Keuls test for multiple compar-
isons; n = 3–8 refers to data from 3 to 8 individual mice or 3 to 8
independent cell isolations. Unpaired Students t-test was used for
comparisons between two groups. A P < 0.05 was considered signiﬁ-
cant.3. Results and discussion
3.1. Hcy upregulated Trx protein expression in human
monocytes in vitro
ROS is an important mediator for Hcy-induced MCP-1
secretion from human monocytes [5]. To examine whether
Hcy directly aﬀects expression of the redox regulator Trx inFig. 2. Role of NADPH oxidase in Hcy-induced Trx protein expres-
sion. Western blot of Trx protein expression in diﬀerentiated THP-1
cells pretreated with the NADPH oxidase inhibitor DPI (10 lM) for
30 min and stimulated with Hcy (100 lM) for 12 h. Data represent
results from three independent experiments. *: P < 0.05 vs. control
(Con), n = 3; #: P < 0.05 vs. Hcy, n = 3.human monocytes in vitro, diﬀerentiated THP-1 cells were
challenged with Hcy. The results showed that Hcy induced a
time- and concentration-dependent upregulation of Trx pro-
tein expression (Fig. 1A and B). As a positive control, H2O2
(50 lM) also caused Trx upregulation in THP-1 cells
(Fig. 1B). As well, Hcy also increased Trx expression in pri-
mary human monocytes (Fig. 1C). In addition, the eﬀect of
Hcy (100 lM) on the expression of other antioxidants were
studied and a time-dependent upregulation of Cu, Zn-SODFig. 3. Eﬀect of Trx overexpression on Hcy-induced ROS production
in A549 cells. Western blot of Trx protein expression in A549 cells
transiently transfected with pcDNA3.1 and pcDNA3.1-Trx plasmid,
for 24 h (A). Transfected cells were stimulated with Hcy (100 lM) for
20 min; ROS production was initiated by NADPH and measured by
luminol-derived chemiluminescence (B). The sum count represents the
amount of ROS production. *P < 0.05 vs. pcDNA3.1 alone, #P < 0.05
vs. Hcy + pcDNA 3.1, n = 3.
Fig. 4. Role of Trx activity in Hcy-induced MCP-1 secretion in
primary human monocytes. ELISA results of MCP-1 secretion in
primary human monocytes pretreated with selenium for 24 h and then
stimulated with Hcy (100 lM) for 3 days. *P < 0.05 vs. Hcy alone,
n = 6.
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tiated THP-1 cells (data not shown).3.2. Hcy induced Trx expression via NADPH oxidase in human
monocytes
Trx expression can be induced via the antioxidant respon-
sive element in its gene promoter upon oxidative stress [11].
Since we previously reported, Hcy could induce ROS produc-
tion primarily via NADPH oxidase in human monocytes [5],
we investigated whether Hcy-induced Trx expression de-
pended on NADPH oxidase. Hcy-induced upregulation of
Trx in THP-1 cells could be attenuated by DPI (10 lM), a
speciﬁc inhibitor of NADPH oxidase (Fig. 2), suggesting that
Hcy-induced upregulation of Trx depends on NADPH oxi-
dase activity.Fig. 5. HHcy accelerated the decrease of Trx expression in ApoE/
ApoE/ mice fed water with high Hcy content for 2, 4 and 6 weeks (8, 10
stained with oil-red O (A). Trx mRNA level in peritoneal macrophages fro
mRNA levels are relative to the expression of 6-week-old animals (6w-ApoE
ApoE/, n = 3 (B). Mean aortic root lesion areas in 8-week-old ApoE/ m
weeks (8w-HHcy-ApoE/) were quantiﬁed. *P < 0.05, 8w-ApoE/ vs. 8w-H
of 8-week-old ApoE/ mice (8w-ApoE/) and 6-week-old ApoE/ mice fe
PCR. *P < 0.05 8w-ApoE/ vs. 8w-HHcy-ApoE/, n = 6 (D).3.3. Trx overexpression suppressed Hcy-induced ROS
production
A general and important function of Trx in cell signaling
and defense against oxidative stress is to donate an electron
donor to the ubiquitous family of Trx peroxidases, which cat-
alyzes the reduction of H2O2 [7]. To evaluate the role of Trx in
Hcy-induced production of ROS, we transfected Trx plasmids
into A549 cells. Trx expression was signiﬁcantly increased in
transfected cells (Fig. 3A). Horseradish peroxidase-catalysed
luminol chemiluminescence was used to monitor production
of ROS, especially H2O2, in cells. Hcy treatment (100 lM) sig-
niﬁcantly enhanced ROS production, which was suppressed by
Trx overexpression (Fig. 3B). These data imply that overex-
pression of Trx can suppress Hcy-induced ROS production.
Therefore, Hcy-induced upregulation of Trx might represent
a compensation to inhibit oxidative stress within a short time.mice. HHcy-accelerated early atherosclerotic lesions in 6-week-old
, 12 w-HHcy ApoE/). Representative serial sections of aortic roots
m 6, 8, 10 and 12-week-old ApoE/ mice quantiﬁed by qRT-PCR.
/). *P < 0.05 vs. 6-week-old ApoE/, n = 3; #P < 0.05 vs. 8-week-old
ice (8w-ApoE/) and 6-week-old ApoE/ mice fed Hcy water for 2
Hcy-ApoE/, n = 8 (C). Trx mRNA level in peritoneal macrophages
d Hcy water for 2 weeks (8w-HHcy-ApoE/) were quantiﬁed by qRT-
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secretion in human monocytes
Our previous study showed pretreating cells with 1 lM
sodium selenite for 24 h is an eﬃcient method to enhance
Trx reductase and Trx activity. We also ruled out any possible
toxic eﬀects of 1 lM sodium selenite on cells [12]. To evaluate
the role of Trx in Hcy-induced MCP-1 secretion, we pretreated
primary human monocytes with 1 lM sodium selenite for 24 h.
Hcy (100 lM) signiﬁcantly enhanced MCP-1 secretion which
was abolished with 1 lM selenium pretreatment (Fig. 4), indi-
cating that increased Trx activity can abolish Hcy-induced in-
crease in MCP-1 secretion in human monocytes. The
antioxidant Trx might protect against Hcy-induced inﬂamma-
tion in monocytes and further protect against Hcy-accelerated
atherosclerosis by the compensation within a short time.
3.5. HHcy accelerated the decrease of Trx expression in
ApoE/ mice
We previously developed an animal model with HHcy by
feeding 6-week-old ApoE/ mice with water supplemented
with Hcy for addition 4 weeks. Total plasma Hcy level was
positively correlated with mean aortic root lesion area in the
HHcy ApoE/ mice [9]. To further evaluate the correlation
between atherosclerotic lesion formation and Trx expression
in ApoE/ and HHcy ApoE/ mice, we fed 6-week-old
ApoE/ mice with regular water or water containing high
Hcy content for 2, 4 and 6 weeks (8–12-week-old HHcy
ApoE/). ApoE/ mice fed with regular water developed
spontaneous atherosclerotic plaques during 10–12-week-old,
and HHcy accelerated atherosclerotic lesion formation in
8–12-week-old HHcy ApoE/ compared with 8–12-week-old
ApoE/ mice alone (Fig. 5A). Hoen et al. [13] have reported
that the expression of many antioxidant enzymes such as cat-
alase-1, SOD, Gpx and glutathione S-transferase were signiﬁ-
cantly increased in the aortic arch of ApoE/ mice during
early stage of lesion formation, and then declined thereafter.
In our current study, we found similar pattern of Trx expres-
sion in peritoneal macrophages from ApoE/ mice. The rela-
tive mRNA level of Trx was higher, by 2-fold, in macrophages
of 8-week-old ApoE/ mice than in those of 6-week-old
ApoE/ mice, and then declined markedly with lesion devel-
opment in 10–12-week-old ApoE/ mice (Fig. 5B). Interest-
ingly, although ApoE/ mice fed with and without Hcy did
not diﬀer in plasma concentration of TC and TG (Table 1),
6-week-old ApoE/ mice fed with Hcy water, even only for
2 weeks (8-week-old HHcy ApoE/), showed accelerated le-
sion formation (Fig. 5C), and in accordance, decrease of Trx
expression was earlier in these macrophages of 8-week-old
HHcy ApoE/ as compared with those of 8-week-old
ApoE/-alone signiﬁcantly (Fig. 5D). These data suggest that
HHcy-induced sustained oxidative stress might reduce theTable 1
Plasma levels of Hcy, TC, and TG.
Groups n Hcy (lM) TC (mM) TG (mM)
8w-ApoE/ 8 5.7 ± 0.72 7.84 ± 0.54 1.07 ± 0.05
8w-HHcy ApoE/a 8 16.81 ± 1.35a 8.02 ± 0.69 0.99 ± 0.06
TC, total cholesterol; TG, triglycerides.
aSix-week-old ApoE/ mice were fed regular water or water with high
Hcy content for 2 weeks. Values are mean ± S.E.M.; P < 0.05 as
compared with 8w-ApoE/ mice.antioxidant capacity of the macrophage, which may, at least
in part, account for macrophage inﬂammation and accelerate
atherosclerotic formation in vivo.
We also found that Hcy could induce a time-dependent
upregulation of Cu, Zn-SOD in human monocytes. Nishio
and Watanabe [14] showed with rat aorta smooth muscle cells
that Hcy decreased Gpx activity and increased SOD activity
but had no eﬀect on catalase activity. Wilcken et al. [15] re-
ported a positive correlation between extracellular SOD and
total Hcy level in HHcy patients. Hcy-induced upregulation
of SOD and Trx in monocytes might represent a protective
antioxidant response to Hcy-induced oxidative damage and
MCP-1 secretion and might contribute to reducing cardiovas-
cular risk in patients with early HHcy. SOD expression follow-
ing Hcy treatment of ApoE/ mice may have the similar
expression pattern with Trx in HHcy ApoE/ mice. Addi-
tional studies are ongoing in our laboratory to further investi-
gate Hcy eﬀect on antioxidant, such as Trx and SOD
expression in HHcy patients.
In conclusions, our studies demonstrate that the antioxidant
Trx might play an important role in HHcy-accelerated athero-
sclerosis. In human monocytes in vitro, Hcy rapidly operates
through NADPH oxidase to upregulate the expression of Trx
to inhibit oxidative stress and MCP-1 secretion within a short
time. However, this compensation is not strong enough to pre-
vent HHcy-induced sustained oxidative stress, which ﬁnally
inhibits the Trx expression and causes macrophage inﬂamma-
tion, and further accelerates the development of atherosclero-
sis. Thus, our ﬁndings provide new insight into understanding
HHcy-mediated atherogenesis, suggesting a cue to prevent
the progress of this process by modulating Trx activity.
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